Catalent

Activities: Manufacturing Ingredients

Trending Articles

  1. What is ISO 8 cleanroom classification? Each cleanroom class is denoted by a maximum concentration of particles per cubic meter or cubic foot of air. ISO 8 is the second lowest cleanroom classification
  2. Combustible dust in pharma: An elusive but very real risk Controlling contamination and controlling hazards simultaneously in today's cleanrooms is difficult, sometimes even oppositional. Many operations have serious gaps that are...
  3. AdvanceTEC selected by Repeat Global CDMO for large-scale biotech investment Strategic partnership to drive innovation in biotech manufacturing
  4. CALL FOR 2025 SPEAKERS: Share your voice at the Cleanroom Technology Conference Are you an expert in cleanroom technology or contamination control? We are seeking dynamic speakers to share their insights on the latest developments and innovations in the...
  5. Controlled environment expert SRBA introduces QR-LINK for projects SRBA is now using a QR-LINK for its controlled environment facilities in its BIM model to better coordinate between those involved in the design, realisation, and operation of...

Upcoming event

CPhI Worldwide

8–10 October 2023 | Exhibition | Fiera Milano, Italy See all

Related Content

Design & Build

Catalent uses Gerflor Grade A compliant cleanroom floor in European Centre of Excellence

More than 1500 sqm of Gerflor Mipolam Biocontrol Clean flooring has been installed at Catalent's European Centre of Excellence
Finance

Micron pledges $100bn investment towards “Megafab” facility

New Green CHIPS Community Fund to invest $500 million in community and workforce development over time
Containment

Catalent plans $10m investment in isolator tech for micronisation

The CDMO has announced an expansion to its micronisation capabilities for highly potent drug compounds in the US and UK
Manufacturing

Big names announced for leading Pharma and Cleanroom conference

The Cleanroom Technology Conference and Manufacturing Chemist Live collaboration will take place on the 10-11 November. Delegate tickets are currently available
Pharmaceutical

Catalent receives FDA approval as an additional manufacturing site for AveXis' Gene Therapy

The global provider of advanced drug delivery technologies will produce the commercial drug substance intermediate for AveXis’ spinal muscular atrophy (SMA) gene therapy at its manufacturing facility located in Harmans, Maryland
Packaging

Catalent Biologics completes $14m medicine packaging expansion

US-based Catalent has completed a 15,000 sqft expansion at its Bloomington, Indiana facility
Containment

The rise of HPAPIs: Putting safety first

The increasing focus on highly potent active pharmaceutical ingredients (HPAPIs) in pharmaceutical development pipelines has led to a growing requirement for the capability to safely handle and contain these hazardous ingredients. Dr Kevin Robinson investigates
Subscribe now